Olaparib plus bevacizumab as maintenance therapy in patients with newly diagnosed, advanced ovarian cancer: Japan subset from the PAOLA-1/ENGOT-ov25 trial.
Keiichi FujiwaraHiroyuki FujiwaraHiroyuki YoshidaToyomi SatohKan YonemoriShoji NagaoTakashi MatsumotoHiroaki KobayashiHughes BourgeoisPhilipp HarterAnna Maria MosconiIsabel Palacio VazquezReinthaller AlexanderTomoko FujitaPhilip RoweEric Pujade-LauraineIsabelle L Ray-CoquardPublished in: Journal of gynecologic oncology (2021)
ClinicalTrials.gov Identifier: NCT02477644.